8-KLeadership ChangesExhibits & Filings

BOSTON SCIENTIFIC CORP 8-K Report, Executive Changes (Mar 3, 2014)

Filed March 3, 2014For Securities:BSX

Summary

Boston Scientific Corporation (BSX) filed an 8-K on March 3, 2014, primarily to announce a change in its Board of Directors. Effective March 1, 2014, the Board's size was increased from eleven to twelve members with the appointment of Edward J. Ludwig. Mr. Ludwig will serve until the next annual stockholders' meeting and will receive compensation consistent with the company's non-employee director program, including a prorated cash retainer and a restricted stock grant. This appointment suggests a potential strengthening or evolution of the board's composition. Investors may view this as a strategic move to bring in new expertise or perspectives, although the specific impact on future strategy or performance is not detailed in this filing. The company also noted its intent to enter into a standard indemnification agreement with Mr. Ludwig.

Key Highlights

  • 1Boston Scientific appointed Edward J. Ludwig as a new director to its Board of Directors.
  • 2The size of the Board of Directors was increased from eleven to twelve members.
  • 3Mr. Ludwig's appointment is effective March 1, 2014, and he will serve until the next annual meeting of stockholders.
  • 4Mr. Ludwig will receive standard compensation for non-employee directors, including a prorated cash retainer of $13,562.
  • 5He will also receive a prorated restricted stock grant valued at $31,644, vesting at the end of his term.
  • 6The company will enter into a standard indemnification agreement with Mr. Ludwig, similar to those with other directors.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce the appointment of a new director, Edward J. Ludwig, to Boston Scientific's Board of Directors and the subsequent increase in the board's size.

Mr. Ludwig will receive prorated compensation based on the company's non-employee director program. This includes a cash retainer of $13,562 and a restricted stock grant valued at $31,644, which will vest at the end of his term. The exact number of shares for the stock grant will be determined on April 1, 2014.

The filing states that the Board's size was increased from eleven to twelve directors upon the recommendation of the Nominating and Governance Committee. The specific strategic reasons for adding a new director were not detailed in this filing, but it generally indicates an effort to enhance board composition or expertise.

No, this 8-K filing is solely focused on the board composition change. It does not include updates on financial results, operational performance, or material agreements beyond the standard director appointment details and indemnification agreement.